Reduced serum paraoxonase-1 levels in vitiligo: Further evidence of oxidative stress

Redox Report

Volumn 17, Issue 5, 2012, Pages 214-218

  Yesilova, Yavuz ^a   Turan, Enver ^a   Ucmak, Derya ^b   Selek, Sahabettin ^c   Yavuz, Ibrahim Halil ^d   Tanrikulu, Osman ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d Sivas Numune Hospital   (Turkey)

Author keywords

Oxidative stress index; Paraoxonase 1; Vitiligo

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CATALASE; CERULOPLASMIN;

ADULT; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VITILIGO;

ADOLESCENT; ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CATALASE; CERULOPLASMIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; VITILIGO; YOUNG ADULT;

EID: 84867689682     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000025     Document Type: Article

References (40)

1. Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 2009; 61(3):411-20.
2. Glassman SJ. Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond) 2011;120(3):99-120.
3. Cheng YP, Chiu HY, Jee SH, Tsai TF. Excimer light photototherapy of segmental and non-segmental vitiligo: experience in Taiwan. Photodermatol Photoimmunol Photomed 2012; 28(1):6-11.
4. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999;141(2):301-3.
5. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo. A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011; 65(3):473-91.
6. Shah H, Mehta A, Astik B. Clinical and sociodemographic study of vitiligo. Indian J Dermatol Venereol Leprol 2008; 74(6):701.
7. Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B, et al.: Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 2009, 75(3):268-271.
8. Jalel A, Hamdaoui MH: Study of total antioxidant status and glutathione peroxidase activity in Tunisian vitiligo patients. Indian J Dermatol 2009, 54(1):13-16.
9. Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol 2009;19(6):576-80.
10. Arican O, Kurutas EB: Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2008, 17(1):12-16.
11. Hasse S, Gibbons NC, Rokos H, Marles LK, Schallreuter KU: Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol 2004, 122(2):307-313.
12. Agrawal D, Shajil EM, Marfatia YS, Begum R: Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004, 17(3):289-294.
13. Yildirim M, Baysal V, Inaloz HS, Can M. The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol 2004;18(6):683-6.
14. Ines D, Sonia B, Riadh BM, Amel el G, Slaheddine M, Hamida T, et al.: A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res 2006, 298(4):147-152.
15. Hazneci E, Karabulut AB, Ozturk C, Batcioglu K, Dogan G, Karaca S, et al.: A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 2005, 44(8):636-640.
16. Dell'Anna ML, Urbanelli S, Mastrofrancesco A, Camera E, Iacovelli P, Leone G, et al.: Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 2003, 16(5):553-559.
17. Chakraborty DP, Roy S, Chakraborty AK. Vitiligo, psoralen, and melanogenesis: some observations and understanding. Pigment Cell Res 1996;9(3):107-16.
18. Tsiskarishvili NV, Tsiskarishvili Ts I. [Antioxidants in vitiligo treatment]. Georgian Med News 2006;(134):80-3.
19. Spencer JD, Gibbons NC, Rokos H, Peters EM, Wood JM, Schallreuter KU. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Invest Dermatol 2007; 127(2):411-20.
20. Schallreuter KU, Moore J, Wood JM, Beazley WD, Gaze DC, Tobin DJ, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999;4(1):91-6.
21. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69(4): 541-50.
22. Dammak I, Boudaya S, Ben Abdallah F, Turki H, Attia H, Hentati B. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol 2009;48(5):476-80.
23. Cakmak A, Zeyrek D, Atas A, Selek S, Erel O: Oxidative status and paraoxonase activity in children with asthma. Clin Invest Med 2009, 32(5):E327-334.
24. Karsen H, Sunnetcioglu M, Ceylan RM, Bayraktar M, Taskin A, Aksoy N, et al.: Evaluation of oxidative status in patients with Fasciola hepatica infection. Afr Health Sci 2011, 11 Suppl 1:S14-18.
25. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998;44(11):2313-9.
26. Alp R, Selek S, Alp SI, Taskin A, Kocyigit A: Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 2010, 14(10):877-882.
27. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112-9.
28. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38(12):1103-1111.
29. Jain A, Mal J, Mehndiratta V, Chander R, Patra SK. Study of oxidative stres in vitiligo. Indian J Clin Biochem 2011;26(1): 78-81.
30. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 2003;17(6):663-9.
31. Hann SK, Chun WH. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Hann SK, Nordlund JJ (eds.). Vitiligo. Oxford: Blackwell Science, 2000: 137-41.
32. Khan R, Satyam A, Gupta S, Sharma VK, Sharma A: Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res 2009, 301(10):731-737.
33. Delmas-Beauvieux MC, Peuchant E, Couchouron A, Constans J, Sergeant C, Simonoff M, Pellegrin JL, Leng B, Conri C, Clerc M, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996;64(1):101-107.
34. Passi S, Grandinetti M, Maggio F, Stancato A, De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11(2):81-5.
35. Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, UstdalM. Serum paraoxonase activity is decreased in the active stage of Behcet's disease. Br J Ophthalmol 2004;88(10):1256-8.
36. Usta M, Turan E, Aral H, Inal BB, Gurel MS, Guvenen G: Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome. J Clin Lab Anal 2011, 25(4):289-295.
37. Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Br J Dermatol 2012;166(1):204-7.
38. Isik A, Koca SS, Ustundag B, Selek S. Decreased total antioxidant response and increased oxidative stress in Behcet's disease. Tohoku J Exp Med 2007;212(2):133-41.
39. Senti M, Tomas M, Fito M, Weinbrenner T, Covas MI, Sala J, et al.: Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 2003, 88(11):5422-5426.
40. Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H, Robert M, Quist D, Arveiler B: Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo. Int J Dermatol 2002, 41(10):640-642.